Beta-sitosterols: Research, Dosing, and Where to Buy in 2026
A research-first profile for Beta-sitosterols (beta-sitosterols), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.
Beta-sitosterols is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 6 PubMed-cited papers for Beta-sitosterols, each linked to its source.
- Also indexed as beta-sitosterols.
- 0 aggregated dosing-protocol mentions from source transcripts.
- 6 PubMed-indexed citations listed in the research table below.
- 0 vendor recommendations captured from named experts.
What is Beta-sitosterols?
Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.
Beta-sitosterols Dosing Protocols
The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.
No transcript-derived dosing mentions in current source set.
Where to Buy Beta-sitosterols in 2026
No tracked vendor recommendations for Beta-sitosterols yet. See our vendor directory.
Side Effects and Safety
Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.
User Reviews
User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.
Research Efficacy Snapshot
Published efficacy percentages cited in PubMed trials and named-expert reports about Beta-sitosterols. Each line links to the original source.
- "3 trials used non-glucosidic B-sitosterols and one utilized a preparation that contained 100% B-sitosteryl-B-D-glucoside." · Wilt T et al, 2000 PubMed
- "The weighted mean difference (WMD) for the IPSS was -4.9 IPSS points (95%CI = -6.3 to -3.5, n = 2 studies)." · Wilt T et al, 2000 PubMed
- "The WMD for peak urine flow was 3.91 ml/sec (95%CI = 0.91 to 6.90, n = 4 studies) and the WMD for residual volume was -28.62 ml (95%CI = -41." · Wilt T et al, 2000 PubMed
- "The trial using 100% B-sitosteryl-B-D-glucoside (WA184) show improvement in urinary flow measures." · Wilt T et al, 2000 PubMed
- "Withdrawal rates for men assigned to B-sitosterol and placebo were 7.8% and 8." · Wilt T et al, 2000 PubMed
- "For the two studies reporting the International Prostate Symptom Score (IPSS), the weighted mean difference (WMD) against placebo was -4.9 IPSS points (95% confidence interval, CI,-6.3 to-3.5)." · Wilt T et al, 1999 PubMed
- "The WMD for peak urinary flow rate was 3.91 mL/s (95% CI 0.91 to 6.90, four studies) and for residual volume the WMD was -28.62 mL (95% CI-41.42 to-15.83, four studies)." · Wilt T et al, 1999 PubMed
- "Withdrawal rates for men assigned to beta-sitosterol and placebo were 7.8% and 8.0% (not significant), respectively." · Wilt T et al, 1999 PubMed
Research and Studies
6 PubMed-indexed papers reference Beta-sitosterols. Top 6 shown.
Legal Status
Beta-sitosterols is presented here as a research compound. FDA approval status, scheduling, WADA status, and state-specific telehealth rules may apply. Always verify current regulatory status. Last verified: 2026-07-09.
Frequently Asked Questions
Is Beta-sitosterols FDA-approved?
Beta-sitosterols is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.
How much research has been published on Beta-sitosterols?
6 PubMed-indexed paper(s) reference Beta-sitosterols in our current research feed. See the Research and Studies section above for citations.